MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$107,322K
(-12.38%↓ Y/Y)
Income tax benefit
(expense)
-$1,976K
(-127.66%↓ Y/Y)
Investment income, net
$18,471K
(-6.24%↓ Y/Y)
Loss before income
taxes
-$109,298K
(-223.71%↓ Y/Y)
Total non-operating
income, net
$18,452K
(-85.69%↓ Y/Y)
Product
$155,421K
License
$2,761K
Other (expense)
income, net
-$19K
(-101.56%↓ Y/Y)
Loss from operations
-$127,750K
(41.20%↑ Y/Y)
Revenues
$158,182K
(20.60%↑ Y/Y)
Total cost and
operating expenses
$285,932K
(-17.94%↓ Y/Y)
Research and development
expense
$148,135K
(-34.94%↓ Y/Y)
Selling, general and
administrative
$120,587K
(4.45%↑ Y/Y)
Cost of product
revenue
$14,714K
(178.73%↑ Y/Y)
Cost of license
revenue
$2,496K
Back
Back
Income Statement
source: myfinsight.com
Day One Biopharmaceuticals, Inc. (DAWN)
Day One Biopharmaceuticals, Inc. (DAWN)